As CEO of Cellcolabs, Mattias Bernow breaks down the science, safety, and real promise of mesenchymal stem cells (MSCs). From anti-aging and inflammation to autoimmune issues and recovery, MSCs are emerging as one of the most powerful tools in modern medicine. In this eye-opening conversation, Mattias explains how stem cells actually work, what separates hype from science, and why quality (like GMP certification) is critical. We explore how stem cells could shift the future of healthcare—from invasive surgeries to simple infusions—and what’s still holding them back. Whether you’re longevity-curious or health-obsessed, this episode lays out the truth—and the timeline—of when stem cells could go mainstream. 📌 Expect to learn: How MSCs reduce inflammation and regenerate tissue Why this isn’t the fountain of youth—but maybe something better Why GMP-certified stem cells are non-negotiable for safety The difference between autologous and allogeneic stem cells What Brian Johnson got treated for (and what changed) The shocking impact of surgery on lifespan The real bottlenecks stopping stem cells from going mainstream
Yuta Lee Reveals the Key to Living 100+ Disease-Free (It’s Not What You Think)
Yuta Lee is a biotech founder and longevity entrepreneur on a mission to reverse aging


